Clinical
Washout Period
A drug-free interval between treatments in a crossover trial to eliminate carryover effects.
Definition
Washout duration is chosen based on drug half-life — typically at least 5× the half-life to ensure >96% clearance. Insufficient washout biases crossover results.
Related terms
Back to the full peptide glossary.